EURUSD: Life after Parity
Recently, for the first time in two decades, the euro reached parity with the US dollar…
Exuberance and Optimism Keep Going
Information is not investment advice
Midday Market View
Russian health ministry has approved coronavirus vaccine developed by Moscow's Gamaleya Institute. He hopes Russia will start mass production of coronavirus vaccine very soon. European indices are hovering near 2% gains on the session now with US futures also creeping higher.
Midday Key Point
- Germany August ZEW survey current situation comes at -81.3 vs -69.5 than expected.
- Russia president Putin says have approved first Russian-produced coronavirus vaccine.
Similar
Earnings Season Forecast is Surprising
The second earnings season of 2022 has almost begun. From banks and tech stocks to cars and the retail sector: in this outlook, we covered the most promising releases of this summer and made several projections on the companies’ prospects.
Indices and Stocks in the Red
The stock market has reversed, and now it’s going lower and lower…
Popular
United Nations Call the Fed to Cut Rates
A United Nations agency is warning that the central bank’s actions create a high risk of pushing the global economy into recession.
It’s Time to Look at New Zealand
Inflation in New Zealand is the highest since 1990, edging to 7.3% in Q2 2022. The currency is under heavy pressure as the Reserve Bank of New Zealand is trying to reverse the inflationary spiral. The week ahead will give us a valuable clue about the country’s monetary policy, and we are here to talk about that.
The CAD vs. the World: Mid-Term Scenarios for the Currency
In the middle of September 2022, the Canadian dollar has fallen to a 2-year low against the USD.
Choose your payment system
